Unknown

Dataset Information

0

Genotypic and phenotypic properties of cattle-associated Campylobacter and their implications to public health in the USA.


ABSTRACT: Since cattle are a major source of food and the cattle industry engages people from farms to processing plants and meat markets, it is conceivable that beef-products contaminated with Campylobacter spp. would pose a significant public health concern. To better understand the epidemiology of cattle-associated Campylobacter spp. in the USA, we characterized the prevalence, genotypic and phenotypic properties of these pathogens. Campylobacter were detected in 181 (19.2%) out of 944 fecal samples. Specifically, 71 C. jejuni, 132 C. coli, and 10 other Campylobacter spp. were identified. The prevalence of Campylobacter varied regionally and was significantly (P<0.05) higher in fecal samples collected from the South (32.8%) as compared to those from the North (14.8%), Midwest (15.83%), and East (12%). Pulsed Field Gel Electrophoresis (PFGE) analysis showed that C. jejuni and C. coli isolates were genotypically diverse and certain genotypes were shared across two or more of the geographic locations. In addition, 13 new C. jejuni and two C. coli sequence types (STs) were detected by Multi Locus Sequence Typing (MLST). C. jejuni associated with clinically human health important sequence type, ST-61 which was not previously reported in the USA, was identified in the present study. Most frequently observed clonal complexes (CC) were CC ST-21, CC ST-42, and CC ST-61, which are also common in humans. Further, the cattle associated C. jejuni strains showed varying invasion and intracellular survival capacity; however, C. coli strains showed a lower invasion and intracellular survival potential compared to C. jejuni strains. Furthermore, many cattle associated Campylobacter isolates showed resistance to several antimicrobials including ciprofloxacin, erythromycin, and gentamicin. Taken together, our results highlight the importance of cattle as a potential reservoir for clinically important Campylobacter.

SUBMITTER: Sanad YM 

PROVIDER: S-EPMC3198382 | BioStudies | 2011-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC2753054 | BioStudies
1000-01-01 | S-EPMC3831628 | BioStudies
2009-01-01 | S-EPMC3985071 | BioStudies
2010-01-01 | S-EPMC2953019 | BioStudies
2012-01-01 | S-EPMC3285770 | BioStudies
2020-01-01 | S-EPMC7604515 | BioStudies
2012-01-01 | S-EPMC3492356 | BioStudies
2021-01-01 | S-EPMC7936128 | BioStudies
2013-01-01 | S-EPMC3675931 | BioStudies
2016-01-01 | S-EPMC4677457 | BioStudies